Literature DB >> 34973597

Acute systemic inhibition of inflammation augments endothelium-dependent dilation in women with a history of preeclamptic pregnancy.

Anna E Stanhewicz1, Gabrielle A Dillon2, Corinna Serviente3, Lacy M Alexander2.   

Abstract

Women who have had preeclampsia demonstrate microvascular endothelial-dysfunction, mediated in part by reduced nitric oxide (NO)-dependent dilation. Preeclamptic pregnancies are associated with elevated inflammation, and inhibition of inflammation attenuates endothelial damage in animal models of preeclampsia. However, it is unclear if inhibition of vascular inflammation improves endothelial function in women after a preeclamptic pregnancy. Using the cutaneous microcirculation as a model, we hypothesized that acute systemic inhibition of vascular inflammation (oral salsalate; 1500 mg/twice daily, 4 days) would improve endothelium- and NO-dependent vasodilation in women with a history of preeclampsia (PE) but not in women with a history of uncomplicated pregnancy (HC). Twelve HC (30 ± 1yrs, 10 ± 2 months postpartum) and 10 PE (30 ± 2yrs, 8 ± 2 months postpartum) participated in a double-blind placebo-controlled study. Following each treatment, 2 intradermal microdialysis fibers were placed in the skin of the ventral forearm for graded infusion of acetylcholine (Ach, 10-7-102mM) or Ach + 15 mM L-NAME (NO synthase antagonist). Red blood cell flux was measured over each site by laser-Doppler flowmetry (LDF). Cutaneous vascular conductance was calculated (CVC = LDF/mean arterial pressure) and normalized to maximum (%CVCmax; 28 mM SNP + local heat 43 °C). ACh-induced (77 ± 3 vs. 92 ± 3%CVCmax; p = 0.01) and NO-dependent (20 ± 6 vs. 33 ± 4%; p = 0.02) vasodilation were attenuated in PE compared to HC. Salsalate augmented ACh-induced (95 ± 2%CVCmax; p = 0.002) and NO-dependent (39 ± 3%; p = 0.009) dilation in PE compared to placebo but had no effect in HC (all p > 0.05). Salsalate treatment augmented endothelium-dependent vasodilation via NO-mediated pathways in women who have had preeclampsia, suggesting that inflammatory signaling mediates persistent endothelial dysfunction following preeclampsia.
Copyright © 2021 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Endothelial dysfunction; Inflammation; Microvascular; Preeclampsia

Mesh:

Substances:

Year:  2021        PMID: 34973597      PMCID: PMC8858855          DOI: 10.1016/j.preghy.2021.12.010

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  50 in total

1.  Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk.

Authors:  Patricia K Agatisa; Roberta B Ness; James M Roberts; Joseph P Costantino; Lewis H Kuller; Margaret K McLaughlin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-04       Impact factor: 4.733

Review 2.  Immunology of pre-eclampsia.

Authors:  Christopher W G Redman; Ian L Sargent
Journal:  Am J Reprod Immunol       Date:  2010-03-23       Impact factor: 3.886

Review 3.  [Hypertensive disorders during pregnancy: Cardiovascular long-term outcomes].

Authors:  B Alvarez-Alvarez; N Martell-Claros; M Abad-Cardiel; J A García-Donaire
Journal:  Hipertens Riesgo Vasc       Date:  2016-07-06

4.  Effect of local warming on forearm reactive hyperaemia.

Authors:  J M Johnson; D S O'Leary; W F Taylor; W Kosiba
Journal:  Clin Physiol       Date:  1986-08

Review 5.  Pre-eclampsia and future cardiovascular risk among women: a review.

Authors:  Raheel Ahmed; Joseph Dunford; Roxana Mehran; Stephen Robson; Vijay Kunadian
Journal:  J Am Coll Cardiol       Date:  2014-03-05       Impact factor: 24.094

6.  Cyclosporin A significantly improves preeclampsia signs and suppresses inflammation in a rat model.

Authors:  Bihui Hu; Jinying Yang; Qian Huang; Junjie Bao; Shaun Patrick Brennecke; Huishu Liu
Journal:  Cytokine       Date:  2016-03-05       Impact factor: 3.861

7.  Prevention of age-related endothelial dysfunction by habitual aerobic exercise in healthy humans: possible role of nuclear factor κB.

Authors:  Ashley E Walker; Rachelle E Kaplon; Gary L Pierce; Molly J Nowlan; Douglas R Seals
Journal:  Clin Sci (Lond)       Date:  2014-12       Impact factor: 6.124

8.  Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia.

Authors:  Brigitte Santner-Nanan; Michael John Peek; Roma Khanam; Luise Richarts; Erhua Zhu; Barbara Fazekas de St Groth; Ralph Nanan
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

9.  Maternal Immune System and State of Inflammation Dictate the Fate and Severity of Disease in Preeclampsia.

Authors:  Xin Zhao; Shuying Chen; Cui Zhao; Fei Xia
Journal:  J Immunol Res       Date:  2021-06-05       Impact factor: 4.818

10.  Preventive effect of aspirin on preeclampsia in high-risk pregnant women with stage 1 hypertension.

Authors:  Jing Huai; Li Lin; Juan Juan; Jiahui Chen; Boya Li; Yuchun Zhu; Mengting Yu; Huixia Yang
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-01-05       Impact factor: 3.738

View more
  1 in total

1.  Short-term salicylate treatment improves microvascular endothelium-dependent dilation in young adults with major depressive disorder.

Authors:  Jody L Greaney; Erika F H Saunders; Lacy M Alexander
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-04-01       Impact factor: 5.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.